$518M
$215,000
0.0% of portfolio
35,766
Q2 2025
Reduced 0.74%
$1.53B
$245,000
0.0% of portfolio
5,335
Q2 2025
Reduced 85.94%
$4.16B
$470,000
0.0% of portfolio
6,503
Q2 2025
Reduced 60.35%
$1.79B
$2.75 Million
0.0% of portfolio
221,785
Q2 2025
Added 93.71%
$6.48B
$5.52 Million
0.0% of portfolio
12,637
Q2 2025
Added 62.97%
$5.2B
$197,000
0.0% of portfolio
1,870
Q2 2025
Added 34.63%
-
$0
0.0% of portfolio
-
Q2 2025
New
$1.31B
$367,000
0.0% of portfolio
167,721
Q3 2024
Reduced 15.17%
$17.5B
$8.5 Million
0.0% of portfolio
36,093
Q2 2025
Added 702.96%
$6.08B
$2.34 Million
0.0% of portfolio
48,067
Q2 2025
Reduced 0.05%
-
$0
0.0% of portfolio
-
Q1 2023
Added 83.33%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 28.02%
$8.95B
$490,000
0.0% of portfolio
9,438
Q2 2025
Added 54.75%
Halozyme Therapeutics Inc
-
$0
0.0% of portfolio
-
Q2 2025
Added 771.6%
Halozyme Therapeutics Inc
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 53.33%
$5.92B
$339,000
0.0% of portfolio
2,392
Q2 2025
Added 39,766.67%
$2.16B
$267,000
0.0% of portfolio
58,314
Q2 2025
Reduced 60.68%
$957M
$290,000
0.0% of portfolio
30,637
Q2 2025
Reduced 47.93%
$2.1B
$201,000
0.0% of portfolio
6,373
Q2 2025
Reduced 83.93%
$3.88B
$742,000
0.0% of portfolio
5,223
Q2 2025
Added 131.21%
$3.39B
$311,000
0.0% of portfolio
22,589
Q2 2025
Reduced 60.7%
$1.41B
$5.13 Million
0.0% of portfolio
33,738
Q2 2025
Added 32.23%
-
$0
0.0% of portfolio
-
Q2 2025
Added 154.02%
$7.83B
$3.16 Million
0.0% of portfolio
30,203
Q2 2025
Added 9.32%
$4.57B
$7.79 Million
0.0% of portfolio
1,300,236
Q2 2025
Reduced 40.23%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 43.72%
$954M
$199,000
0.0% of portfolio
4,367
Q2 2025
Reduced 56.68%
$900M
$189,000
0.0% of portfolio
30,416
Q2 2025
Reduced 57.14%
$9.19B
$13.8 Million
0.0% of portfolio
188,314
Q2 2025
Added 93.67%
$1.78B
$386,000
0.0% of portfolio
56,654
Q2 2025
Added 69.4%
$1.84B
$200,000
0.0% of portfolio
5,215
Q2 2025
Reduced 25.15%
$5.22B
$4.93 Million
0.0% of portfolio
87,295
Q2 2025
Reduced 3.39%
$9.36B
$7.16 Million
0.0% of portfolio
174,199
Q2 2025
Added 7.66%
$3.05B
$2.23 Million
0.0% of portfolio
71,725
Q2 2025
Reduced 31.82%
$1.63B
$243,000
0.0% of portfolio
12,148
Q2 2025
Reduced 59.15%
$2.02B
$233,000
0.0% of portfolio
7,699
Q2 2025
Reduced 59.29%
$9.53B
$513,000
0.0% of portfolio
10,296
Q2 2025
Added 5.34%
$1.84B
$419,000
0.0% of portfolio
8,533
Q2 2025
Reduced 61.38%
$1.24B
$223,000
0.0% of portfolio
20,839
Q2 2025
Reduced 54.85%
$1.82B
$287,000
0.0% of portfolio
6,696
Q2 2025
Reduced 57.7%
Howard Hughes Holdings Inc
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 22.04%
$1.17B
$458,000
0.0% of portfolio
13,704
Q2 2025
Reduced 65.14%
$2.58B
$3.2 Million
0.0% of portfolio
301,379
Q2 2025
Added 61,531.7%
$1.89B
$2.25 Million
0.0% of portfolio
215,938
Q2 2025
Reduced 0.09%
$2.65B
$2.37 Million
0.0% of portfolio
157,432
Q1 2025
Reduced 7.53%
$0
$75,000
0.0% of portfolio
125,000
Q4 2023
Added 25.0%
$2.84B
$740,000
0.0% of portfolio
19,831
Q2 2025
Added 660,933.31%
$7.64B
$4.96 Million
0.0% of portfolio
721,355
Q2 2025
Added 1.79%
$2.64B
$548,000
0.0% of portfolio
4,147
Q2 2025
Reduced 59.5%
-
$0
0.0% of portfolio
-
Q2 2025
New